Vinge Logotype
Svenska English 18D7E0DE-2035-40AE-A740-8F45A358A8F4 Login
  1. Home
  2. Mandates
  3. Vinge assists William Hill on its offer for Mr Green & Co
Mandate

Vinge assists William Hill on its offer for Mr Green & Co

October 31, 2018 Capital Markets and Public M&A

William Hill has launched a recommended cash offer to the shareholders in Mr Green & Co, MRG (Nasdaq Stockholm). The total offer value for all shares in MRG amounts to approximately SEK 2.819 billion.     

MRG is a fast-growing, innovative iGaming Group with operations in 13 markets. MRG offers a superior experience in a Green Gaming environment. MRG was founded in 2007 and operates the iGaming sites Mr Green, Redbet, 11.lv, Vinnarum, Bertil, MamaMiaBingo, BingoSjov and BingoSlottet. The Group had a turnover of SEK 1,192 million in 2017 and has over 300 employees.
 
William Hill PLC is one of the world’s leading betting and gaming companies, employing around 16,000 people. William Hill was founded in 1934 and is listed on the London Stock Exchange. 
 
Vinge assists Wiliam Hill and the team consists of Charlotte Levin, David Andersson, Joel Wahlberg, Boris Kotur and Milad Kamali. 
 

Related

Vinge advises Axcel VI and Currentum in connection with the acquisition of Elprojekt Skandinavien

 Vinge advises Axcel VI and the Currentum Group in connection with the acquisition of Elprojekt Skandinavien. The company provides complete electrical installations throughout Sweden, focusing on new construction of logistics properties, production facilities, residential buildings and office buildings. Elprojekt Skandinavien had a revenue of SEK 316 million in 2024.
June 23, 2025

Vinge advises Meribel Pharma Solutions

 Vinge advises Meribel Pharma Solutions in connection with the sale of a production facility specialising in the manufacture of antibiotics to Apotek Produktion & Laboratorier AB ("APL").
June 23, 2025

Vinge has advised Hansa Biopharma in connection with a directed share issue of approx. SEK 232 million and restructuring of debt financing

 Vinge has advised Hansa Biopharma AB (publ) in connection with a directed share issue, through which Hansa raises gross proceeds of approx. SEK 232 million, and restructuring of debt financing. As part of such debt restructuring, Hansa has in conjunction with the directed share issue set-off debt corresponding to approximately USD 14.9 million of its total debt amount.
June 23, 2025